These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Effect of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on polymorphonuclear neutrophils, monocytes or monocyte-derived macrophages combined with voriconazole against Cryptococcus neoformans. Chiller T; Farrokhshad K; Brummer E; Stevens DA Med Mycol; 2002 Feb; 40(1):21-6. PubMed ID: 11860010 [TBL] [Abstract][Full Text] [Related]
29. The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection. Kasetty G; Bhongir RKV; Papareddy P; Herwald H; Egesten A Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652240 [TBL] [Abstract][Full Text] [Related]
30. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638 [TBL] [Abstract][Full Text] [Related]
31. Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. Villa P; Shaklee CL; Meazza C; Agnello D; Ghezzi P; Senaldi G J Infect Dis; 1998 Aug; 178(2):471-7. PubMed ID: 9697729 [TBL] [Abstract][Full Text] [Related]
32. G-CSF and GM-CSF for treating or preventing neonatal infections. Carr R; Modi N; Doré C Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944 [TBL] [Abstract][Full Text] [Related]
34. Effect of delayed treatment with recombinant human granulocyte colony-stimulating factor on survival and plasma cytokine levels in a non-neutropenic porcine model of Pseudomonas aeruginosa sepsis. Haberstroh J; Wiese K; Geist A; Dursunoglu GB; Gippner-Steppert C; Jochum M; von Specht BU Shock; 1998 Feb; 9(2):128-34. PubMed ID: 9488258 [TBL] [Abstract][Full Text] [Related]
35. Antibody to Mol abrogates the increase in neutrophil phagocytosis and degranulation induced by granulocyte-macrophage colony-stimulating factor. Kletter Y; Bleiberg I; Golde DW; Fabian I Eur J Haematol; 1989 Nov; 43(5):389-96. PubMed ID: 2482194 [TBL] [Abstract][Full Text] [Related]
36. Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection. Giladi M; Porat Y; Blatt A; Shmueli E; Wasserman Y; Kirson ED; Palti Y Antimicrob Agents Chemother; 2010 Aug; 54(8):3212-8. PubMed ID: 20547811 [TBL] [Abstract][Full Text] [Related]
37. Polymorphonuclear leukocytes released from the bone marrow by granulocyte colony-stimulating factor: intravascular behavior. Mukae H; Zamfir D; English D; Hogg JC; van Eeden SF Hematol J; 2000; 1(3):159-71. PubMed ID: 11920185 [TBL] [Abstract][Full Text] [Related]
38. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Cicco NA; Lindemann A; Content J; Vandenbussche P; Lübbert M; Gauss J; Mertelsmann R; Herrmann F Blood; 1990 May; 75(10):2049-52. PubMed ID: 1692493 [TBL] [Abstract][Full Text] [Related]
39. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice. Matsuzaki G; Li XY; Ohyama Y; Nomoto K Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937 [TBL] [Abstract][Full Text] [Related]
40. Alteration of the functional effects of granulocyte-macrophage colony-stimulating factor on polymorphonuclear leukocytes by membrane-fluidizing agents. Buescher ES; McIlheran SM; Banks SM; Vadhan-Raj S Infect Immun; 1990 Sep; 58(9):3002-8. PubMed ID: 2167293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]